Close

Analyst Ratings for Amicus Therapeutics (FOLD)

FOLD Rating Summary

FOLD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on FOLD
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $18.20 (+79%) * Over Last 12-Mos
Rating Score: 6.7 / 10   Percentile Rank: 72%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/19/2023 Morgan Stanley Jeffrey Hung Upgrade Overweight
(Equalweight)
20.00
(15.00)
12.72
(10.17)
-20.05% Details
1/13/2023 Jefferies Vedvati Shrote New Coverage Hold
(N/A)
N/A
(N/A)
12.02
(10.17)
-15.39% Details